sotagliflozin

  1. Northerner

    New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes

    A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes. Principal results were published in the New England Journal of Medicine of a global Phase 3 clinical trial in patients with type 1...
Back
Top